Literature DB >> 26066300

Mouse model of alloimmune-induced vascular rejection and transplant arteriosclerosis.

Winnie Enns1, Anna von Rossum1, Jonathan Choy2.   

Abstract

Vascular rejection that leads to transplant arteriosclerosis (TA) is the leading representation of chronic heart transplant failure. In TA, the immune system of the recipient causes damage of the arterial wall and dysfunction of endothelial cells and smooth muscle cells. This triggers a pathological repair response that is characterized by intimal thickening and luminal occlusion. Understanding the mechanisms by which the immune system causes vasculature rejection and TA may inform the development of novel ways to manage graft failure. Here, we describe a mouse aortic interposition model that can be used to study the pathogenic mechanisms of vascular rejection and TA. The model involves grafting of an aortic segment from a donor animal into an allogeneic recipient. Rejection of the artery segment involves alloimmune reactions and results in arterial changes that resemble vascular rejection. The basic technical approach we describe can be used with different mouse strains and targeted interventions to answer specific questions related to vascular rejection and TA.

Entities:  

Mesh:

Year:  2015        PMID: 26066300      PMCID: PMC4542821          DOI: 10.3791/52800

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  25 in total

1.  Chronic rejection--graft arteriosclerosis.

Authors:  M L Foegh
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

2.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

Authors:  G Tellides; D A Tereb; N C Kirkiles-Smith; R W Kim; J H Wilson; J S Schechner; M I Lorber; J S Pober
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

3.  Cellular and humoral responses to major and minor histocompatibility antigens.

Authors:  C Miller; C W DeWitt
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

4.  AIP1 prevents graft arteriosclerosis by inhibiting interferon-γ-dependent smooth muscle cell proliferation and intimal expansion.

Authors:  Luyang Yu; Lingfeng Qin; Haifeng Zhang; Yun He; Hong Chen; Jordan S Pober; George Tellides; Wang Min
Journal:  Circ Res       Date:  2011-06-23       Impact factor: 17.367

5.  Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.

Authors:  Elina Minami; Michael A Laflamme; Jeffrey E Saffitz; Charles E Murry
Journal:  Circulation       Date:  2005-11-08       Impact factor: 29.690

6.  Tissue distribution, structural characterization, and biosynthesis of Mac-3, a macrophage surface glycoprotein exhibiting molecular weight heterogeneity.

Authors:  M K Ho; T A Springer
Journal:  J Biol Chem       Date:  1983-01-10       Impact factor: 5.157

7.  Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study.

Authors:  H Tsutsui; K M Ziada; P Schoenhagen; A Iyisoy; W A Magyar; T D Crowe; J D Klingensmith; D G Vince; G Rincon; R E Hobbs; M Yamagishi; S E Nissen; E M Tuzcu
Journal:  Circulation       Date:  2001-08-07       Impact factor: 29.690

8.  Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts.

Authors:  Jonathan C Choy; Alexandra Kerjner; Brian W Wong; Bruce M McManus; David J Granville
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

9.  Bim regulates alloimmune-mediated vascular injury through effects on T-cell activation and death.

Authors:  Anna von Rossum; Winnie Enns; Yu P Shi; Grace E MacEwan; Mehrnoush Malekesmaeli; Ryan Brinkman; Jonathan C Choy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04-03       Impact factor: 8.311

10.  The spectrum of coronary artery pathologic findings in human cardiac allografts.

Authors:  D E Johnson; S Z Gao; J S Schroeder; W M DeCampli; M E Billingham
Journal:  J Heart Transplant       Date:  1989 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.